实施标准路径后重症监护病房吸入一氧化氮使用量的变化。

IF 4 2区 医学 Q1 CRITICAL CARE MEDICINE Pediatric Critical Care Medicine Pub Date : 2024-08-01 Epub Date: 2024-05-24 DOI:10.1097/PCC.0000000000003544
Monique Radman, John McGuire, Paul Sharek, Harris Baden, Andy Koth, Robert DiGeronimo, Darren Migita, Dwight Barry, James B Johnson, Lori Rutman, Surabhi Vora
{"title":"实施标准路径后重症监护病房吸入一氧化氮使用量的变化。","authors":"Monique Radman, John McGuire, Paul Sharek, Harris Baden, Andy Koth, Robert DiGeronimo, Darren Migita, Dwight Barry, James B Johnson, Lori Rutman, Surabhi Vora","doi":"10.1097/PCC.0000000000003544","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator. It is expensive, frequently used, and not without risk. There is limited evidence supporting a standard approach to initiation and weaning. Our objective was to optimize the use of iNO in the cardiac ICU (CICU), PICU, and neonatal ICU (NICU) by establishing a standard approach to iNO utilization.</p><p><strong>Design: </strong>A quality improvement study using a prospective cohort design with historical controls.</p><p><strong>Setting: </strong>Four hundred seven-bed free standing quaternary care academic children's hospital.</p><p><strong>Patients: </strong>All patients on iNO in the CICU, PICU, and NICU from January 1, 2017 to December 31, 2022.</p><p><strong>Interventions: </strong>Unit-specific standard approaches to iNO initiation and weaning.</p><p><strong>Measurements and main results: </strong>Sixteen thousand eighty-seven patients were admitted to the CICU, PICU, and NICU with 9343 in the pre-iNO pathway era (January 1, 2017 to June 30, 2020) and 6744 in the postpathway era (July 1, 2020 to December 31, 2022). We found a decrease in the percentage of CICU patients initiated on iNO from 17.8% to 11.8% after implementation of the iNO utilization pathway. We did not observe a change in iNO utilization between the pre- and post-iNO pathway eras in either the PICU or NICU. Based on these data, we estimate 564 total days of iNO (-24%) were saved over 24 months in association with the standard pathway in the CICU, with associated cost savings.</p><p><strong>Conclusions: </strong>Implementation of a standard pathway for iNO use was associated with a statistically discernible reduction in total iNO usage in the CICU, but no change in iNO use in the NICU and PICU. These differential results likely occurred because of multiple contextual factors in each care setting.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"e347-e357"},"PeriodicalIF":4.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in Inhaled Nitric Oxide Use Across ICUs After Implementation of a Standard Pathway.\",\"authors\":\"Monique Radman, John McGuire, Paul Sharek, Harris Baden, Andy Koth, Robert DiGeronimo, Darren Migita, Dwight Barry, James B Johnson, Lori Rutman, Surabhi Vora\",\"doi\":\"10.1097/PCC.0000000000003544\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator. It is expensive, frequently used, and not without risk. There is limited evidence supporting a standard approach to initiation and weaning. Our objective was to optimize the use of iNO in the cardiac ICU (CICU), PICU, and neonatal ICU (NICU) by establishing a standard approach to iNO utilization.</p><p><strong>Design: </strong>A quality improvement study using a prospective cohort design with historical controls.</p><p><strong>Setting: </strong>Four hundred seven-bed free standing quaternary care academic children's hospital.</p><p><strong>Patients: </strong>All patients on iNO in the CICU, PICU, and NICU from January 1, 2017 to December 31, 2022.</p><p><strong>Interventions: </strong>Unit-specific standard approaches to iNO initiation and weaning.</p><p><strong>Measurements and main results: </strong>Sixteen thousand eighty-seven patients were admitted to the CICU, PICU, and NICU with 9343 in the pre-iNO pathway era (January 1, 2017 to June 30, 2020) and 6744 in the postpathway era (July 1, 2020 to December 31, 2022). We found a decrease in the percentage of CICU patients initiated on iNO from 17.8% to 11.8% after implementation of the iNO utilization pathway. We did not observe a change in iNO utilization between the pre- and post-iNO pathway eras in either the PICU or NICU. Based on these data, we estimate 564 total days of iNO (-24%) were saved over 24 months in association with the standard pathway in the CICU, with associated cost savings.</p><p><strong>Conclusions: </strong>Implementation of a standard pathway for iNO use was associated with a statistically discernible reduction in total iNO usage in the CICU, but no change in iNO use in the NICU and PICU. These differential results likely occurred because of multiple contextual factors in each care setting.</p>\",\"PeriodicalId\":19760,\"journal\":{\"name\":\"Pediatric Critical Care Medicine\",\"volume\":\" \",\"pages\":\"e347-e357\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Critical Care Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/PCC.0000000000003544\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Critical Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PCC.0000000000003544","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

目的:吸入一氧化氮(iNO)是一种选择性肺血管扩张剂。它价格昂贵,使用频繁,而且并非没有风险。支持启动和断奶标准方法的证据有限。我们的目标是通过建立 iNO 使用的标准方法,优化 iNO 在心脏重症监护病房 (CICU)、重症监护病房 (PICU) 和新生儿重症监护病房 (NICU) 的使用:设计:采用前瞻性队列设计和历史对照的质量改进研究:环境:拥有四百七十张床位的独立四级儿童学术医院:患者:2017 年 1 月 1 日至 2022 年 12 月 31 日期间在 CICU、PICU 和 NICU 使用 iNO 的所有患者:测量和主要结果:CICU、PICU和NICU共收治了1687名患者,其中9343人在iNO路径前(2017年1月1日至2020年6月30日),6744人在路径后(2020年7月1日至2022年12月31日)。我们发现,在实施 iNO 使用路径后,CICU 患者开始使用 iNO 的比例从 17.8% 降至 11.8%。我们没有观察到 iNO 使用途径实施前和实施后 PICU 或 NICU 中 iNO 使用率的变化。根据这些数据,我们估计在 CICU 实施标准路径后,24 个月内共节省了 564 天的 iNO(-24%),并节省了相关费用:结论:采用标准路径使用 iNO,CICU 中 iNO 的总使用量在统计学上有明显减少,但 NICU 和 PICU 中 iNO 的使用量没有变化。这些不同的结果很可能是由于每个护理环境的多种背景因素造成的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Changes in Inhaled Nitric Oxide Use Across ICUs After Implementation of a Standard Pathway.

Objectives: Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator. It is expensive, frequently used, and not without risk. There is limited evidence supporting a standard approach to initiation and weaning. Our objective was to optimize the use of iNO in the cardiac ICU (CICU), PICU, and neonatal ICU (NICU) by establishing a standard approach to iNO utilization.

Design: A quality improvement study using a prospective cohort design with historical controls.

Setting: Four hundred seven-bed free standing quaternary care academic children's hospital.

Patients: All patients on iNO in the CICU, PICU, and NICU from January 1, 2017 to December 31, 2022.

Interventions: Unit-specific standard approaches to iNO initiation and weaning.

Measurements and main results: Sixteen thousand eighty-seven patients were admitted to the CICU, PICU, and NICU with 9343 in the pre-iNO pathway era (January 1, 2017 to June 30, 2020) and 6744 in the postpathway era (July 1, 2020 to December 31, 2022). We found a decrease in the percentage of CICU patients initiated on iNO from 17.8% to 11.8% after implementation of the iNO utilization pathway. We did not observe a change in iNO utilization between the pre- and post-iNO pathway eras in either the PICU or NICU. Based on these data, we estimate 564 total days of iNO (-24%) were saved over 24 months in association with the standard pathway in the CICU, with associated cost savings.

Conclusions: Implementation of a standard pathway for iNO use was associated with a statistically discernible reduction in total iNO usage in the CICU, but no change in iNO use in the NICU and PICU. These differential results likely occurred because of multiple contextual factors in each care setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pediatric Critical Care Medicine
Pediatric Critical Care Medicine 医学-危重病医学
CiteScore
7.40
自引率
14.60%
发文量
991
审稿时长
3-8 weeks
期刊介绍: Pediatric Critical Care Medicine is written for the entire critical care team: pediatricians, neonatologists, respiratory therapists, nurses, and others who deal with pediatric patients who are critically ill or injured. International in scope, with editorial board members and contributors from around the world, the Journal includes a full range of scientific content, including clinical articles, scientific investigations, solicited reviews, and abstracts from pediatric critical care meetings. Additionally, the Journal includes abstracts of selected articles published in Chinese, French, Italian, Japanese, Portuguese, and Spanish translations - making news of advances in the field available to pediatric and neonatal intensive care practitioners worldwide.
期刊最新文献
Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation. Targeted Temperature Management After Pediatric Cardiac Arrest: A Quality Improvement Program With Multidisciplinary Implementation in the PICU. Extubation Failure in the PICU: A Virtual Pediatric Systems Database Study, 2017-2021. Assessing the Reliability of the Bleeding Assessment Scale in Critically Ill Children (BASIC) Definition: A Prospective Cohort Study. Protocol for the Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1